Table 3.
Variable | PCL score median (IQR) |
---|---|
Demographics | |
Survey agea | |
Young (≤58.7) | 29.0 (22.0–40.5) |
Old (>58.7) | 25.0 (21.0–34.0) |
Gender | |
Male | 24.0 (20.0–32.0) |
Female | 28.0 (21.0–36.0) |
White | |
Yes | 25.0 (21.0–33.6) |
No | 28.0 (21.0–36.0) |
Private/commercial insurance (primary insurance) | |
Yes | 23.0 (20.0–30.0) |
No | 29.0 (22.5–39.5) |
Income | |
Less than $10,000 | 32.0 (22.0–45.7) |
$10–24,999 | 27.0 (21.0–40.0) |
$25–49,999 | 28.0 (21.0–32.0) |
$50–74,999 | 26.0 (23.0–36.0) |
$75–99,999 | 23.0 (20.5–29.0) |
$100–149,999 | 20.5 (18.0–28.5) |
More than $150,000 | 21.0 (21.0–26.0) |
Education | |
Some HS or less | 28.5 (20.0–33.3) |
HS degree or some college | 25.0 (21.0–34.0) |
4-year college or grad school | 24.5 (21.0–35.0) |
Married or engaged | |
Yes | 24.0 (20.0–30.0) |
No | 29.0 (22.0–42.0) |
History of traumatic event ever in life | |
Yes | 28.0 (21.0–36.0) |
No | 22.0 (19.0–30.0) |
Pre-/peri-transplant characteristics | |
Pre-transplant Diagnosis | |
COPD | 27.0 (21.0–37.0) |
Cystic fibrosis | 26.5 (21.5–41.5) |
Idiopathic pulmonary fibrosis | 24.0 (20.5–29.0) |
PAH | 30.0 (25.0–42.0) |
Other | 27.0 (20.0–36.0) |
Days on waitlista | |
≤88.5 | 25.0 (21.0–32.0) |
>88.5 | 26.0 (20.5–36.0) |
Pulmonary function tests | |
FVC, % predicteda | |
≤48.5 | 24.0 (20.0–35.0) |
>48.5 | 26.0 (21.0–32.5) |
FEV1, % predicteda | |
≤27 | 25.5 (20.5–36.5) |
>27 | 25.0 (21.0–32.0) |
Median most recent oxygen requirement prior to transplant, liters/min (IQR)a | |
≤3 | 26.0 (20.0–34.0) |
>3 | 25.0 (21.0–33.0) |
Six-minute walk test, feeta | |
≤1,057.5 | 25.5 (21.0–34.0) |
>1,057.5 | 25.0 (21.0–34.0) |
Transplant type | |
Bilateral | 27.0 (21.0–34.0) |
Unilateral | 23.0 (20.5–33.6) |
Post-transplant characteristics | |
Pulmonary function tests | |
FVC, % predicteda | |
≤73 | 26.0 (22.0–36.0) |
>73 | 24.0 (19.5–31.5) |
FEV1, % predicteda | |
≤69 | 26.0 (22.0–36.0) |
>69 | 24.0 (19.0–31.0) |
Time since transplant, yearsa | |
≤2.4 | 28.0 (21.0–34.0) |
>2.4 | 24.0 (20.0–34.0) |
Current supplemental oxygen use | |
Yes | 25.0 (22.0–46.0) |
No | 25.0 (20.0–32.5) |
Acute cellular rejection | |
Yes | 28.0 (22.0–40.0) |
No | 24.5 (20.0–32.0) |
Bronchiolitis obliterans syndrome | |
Yes | 30.0 (21.5–42.9) |
No | 24.0 (20.0–32.0) |
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; PAH, pulmonary arterial hypertension.
Continuous variables were dichotomized at their median for descriptive purposes only. They were analyzed as continuous variables